FDA Approval
FDA Permits Marketing of First Medical Device for IBS Pain Relief in Adolescent Patients
U.S. Food & Drug Administration
PR-M06-19-NI-012Jun 13, 2019
Pain Treatment
Eli Lilly Acquires Rights to Non-Opioid Pain Treatment
Nice Insight
PAO-M05-19-NI-038May 31, 2019
FDA Approval
FDA Approves Treatment for Patients with a Type of Inflammatory Arthritis
U.S. Food & Drug Administration
PR-M04-19-NI-001Apr 01, 2019
Clinical Trials
Syntrix Announces First Patient Cohort Dosed in Phase 2 Study of Desmetramadol in Diabetic Neuropathic Pain
Nice Insight
PR-M03-19-NI-058Mar 21, 2019
Phase II
Peptide Logic Awarded A $ 2.9 Million SBIR Phase II Grant To Develop Peripherally-Restricted And Long-Acting Kappa-Opioid Receptor (LA-KOR) Agonists For Moderate-To-Severe Pain
Peptide Logic
PR-M09-18-NI-056Sep 19, 2018